Connection
Brad Constant to Remission Induction
This is a "connection" page, showing publications Brad Constant has written about Remission Induction.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.055 |
|
|
|
-
Mitchel EB, Dolinger MT, Constant B, Wang Z, Guisado D, Gao M, Fusillo S, Baldassano RN, Kelsen J, Dubinsky M, Huang J, Albenberg L. Ustekinumab is safe and effective in pediatric patients with Crohn's disease. J Pediatr Gastroenterol Nutr. 2025 Apr; 80(4):653-663.
Score: 0.055